CardioExcyte 96 – Dr. Marc Rogers

This fruitful working relationship has now been extended to our use of the CardioExcyte 96 phenotypic assay platform, which we utilize to develop and validate human iPSC cardiomyocyte cell lines and assays to meet the post-hERG, predictive cardiac safety testing needs of the drug discovery industry.